Life sciences organisations worldwide trust Ideagen to deliver quality and compliance at scale. See what that looks like for your organisation.
Book a personalized demo
Life sciences software built for compliant, inspection-ready operations
Life sciences organizations don’t need more fragmented point solutions. They need connected quality and compliance. Ideagen brings together document review, quality management, document collaboration and EHS – so every process is backed by validated workflows, structured oversight and audit-ready documentation that holds up under FDA, EMA or any regulatory inspection.
Life sciences organizations trust Ideagen. Here’s why
31%
MedTech leaders aim to cut costs with digital tech investment
10-20%
Profit increase through digital and analytics adoption
5-15%
Improvement through digital and analytics adoption
73%
Companies are using technology to address cybersecurity issues
Built for today’s life sciences regulatory environment
Regulatory complexity in life sciences has never been greater. FDA and EMA expectations around validated systems, electronic signatures and 21 CFR Part 11 compliance are non-negotiable. ICH guideline updates, IVDR/MDR transitions and EMA Policy 70 transparency requirements are reshaping submission and disclosure processes.
Meanwhile, global supply chains demand consistent quality oversight across contract manufacturers – and system validation timelines are consuming months of GxP resource. Life sciences organisations need connected governance that covers every compliance obligation – from document review through to supplier qualification – without slowing development and regulatory programmes down.
Life sciences leaders know these challenges. So do we
FDA/EMA regulatory compliance complexity – complex regulatory landscapes requiring validated quality management systems with 21 CFR Part 11 compliance, electronic signatures and audit-ready documentation trails that satisfy global inspections.
Validation timelines delaying deployment – lengthy system validation processes (6–8 months typical) delaying software deployments and product launches, consuming GxP resources and extending time-to-market for critical therapeutics and devices.
Regulatory submission review bottlenecks – sequential document review cycles for regulatory submissions, clinical study reports and labelling, where multi-stakeholder approval involving up to 200+ reviewers delays filings by weeks or months.
Global supply chain quality consistency – managing quality across complex, global supply chains with multiple contract manufacturers, requiring consistent non-conformance management, supplier qualification and CAPA workflows.
Evolving standards and regulatory horizon – keeping pace with evolving requirements (ICH guidelines, EMA Policy 70, IVDR/MDR transitions) while maintaining compliance across existing product portfolios and development pipelines.
Clinical document redaction and EMA Policy 70 – secure redaction and external sharing of clinical documents for regulatory transparency requirements, where manual processes create compliance risk and delay submission timelines.
Everything life sciences organisations need. Connected
Document Review
A purpose-built document review platform with validated, 21 CFR Part 11-compliant workflows – so regulatory submissions, clinical study reports and labelling approvals are always inspection-ready.
Parallel review workflows replace sequential approval bottlenecks – supporting up to 200+ reviewers simultaneously with automated routing, version control and real-time status tracking that compresses submission timelines. Electronic signatures and a complete, tamper-evident audit trail meet FDA and EMA requirements for validated systems – so every document action is evidenced, traceable and inspection-ready Configurable review workflows adapt to regulatory submission requirements, SOP reviews and labelling approvals – ensuring consistent document quality across every programme and jurisdiction.
Document Collaboration
Secure, structured workspaces that make clinical document sharing, review and external collaboration frictionless – for life sciences organisations where data security and regulatory transparency are non-negotiable.
Secure cloud-based workspaces replace fragmented email threads for clinical document exchange – giving internal teams and external partners a single, organised space for every regulatory submission and transparency obligation FedRAMP-authorised and ISO/IEC 27001:2013 certified – ensuring sensitive clinical documentation is protected to the highest security standard, meeting the requirements of FDA-regulated environments Automatic audit trails track every document action, version and approval – so firms can evidence EMA Policy 70 compliance and data protection obligations without manual compilation.
Quality
A connected quality management platform built for life sciences – embedding validated workflows, CAPA management, supplier qualification and training compliance into every process across the product lifecycle.
Validated QMS workflows meet 21 CFR Part 11 and ISO 13485 requirements – with structured IQ/OQ/PQ documentation support that reduces system validation timelines and GxP resource consumption Connected non-conformance, deviation and CAPA management creates a complete, auditable quality record – so every corrective action is traceable from root cause through to closure and effectiveness review Supplier qualification and ongoing performance monitoring across global contract manufacturers ensures consistent quality standards are enforced – with audit-ready evidence always available at inspection.
EHS
A unified EHS platform that protects life sciences workforces, manages chemical and environmental compliance, and builds inspection-ready safety records across every facility and jurisdiction.
Incident, near-miss and safety observation workflows create a consistent, evidence-based safety record – so organisations can demonstrate duty-of-care compliance and continuous improvement to regulators Chemical management and environmental monitoring tools ensure GHS and REACH obligations are met – with structured workflows replacing the manual processes that create compliance exposure in laboratory and manufacturing environments Workforce and contractor safety management links inductions, training records and permit-to-work processes – ensuring every individual operating in a life sciences facility meets the required competency and compliance standard.
See it in action
Frequently Asked Questions
21 CFR Part 11 compliance requires validated systems with electronic signatures, audit trails and access controls that demonstrate the integrity and authenticity of electronic records. A purpose-built document management platform with validated workflows and tamper-evident audit trails supports compliance without relying on manual processes.
A validated QMS in life sciences is a system that has been formally tested and documented to confirm it performs consistently and meets regulatory requirements – including 21 CFR Part 11, ISO 13485 and GxP standards. Validation typically involves IQ, OQ and PQ protocols that generate inspection-ready evidence of system fitness for purpose.
Organisations manage regulatory change by centralising horizon scanning, assessing impact through structured workflows and implementing updates consistently across product portfolios and jurisdictions. A connected compliance platform reduces the risk of missed obligations and inconsistent implementation across sites.
Review cycle times are reduced by replacing sequential, email-based approval with parallel, structured workflows that route documents automatically, track review status in real time and enforce completion deadlines. A purpose-built document review platform with electronic signatures can support large reviewer populations without adding coordination overhead.
Life sciences organisations should look for validated, 21 CFR Part 11-compliant workflows, electronic signatures, configurable audit trails and role-based access controls. Scalability across global sites, integration between quality and document management functions, and alignment with FDA, EMA and ISO standards are also critical considerations.
Still have questions?
Not every question fits a FAQ. If you want a straight conversation about your specific compliance or quality challenge, our life sciences team is ready when you are.